Clinical Trials

This is a partial list of clinical trials for individuals living with Spinal Cord Injury (SCI). For a complete list, please visit:

https://www.clinicaltrials.gov

 

Sponsor: StemCells, Inc

For all information, including complete inclusion and exclusion criteria, as well as locations of this trial, please follow link below.
https://www.clinicaltrials.gov/ct2/show/NCT02163876

Condition

  • Traumatic cervical spinal cord injury (cSCI) with C5-C7
  • SCI injury classification (AIS) Grades A, B or C
  • Minimum of 12 weeks post-injury prior to Screening
  • 18 Years to 60 Years

Intervention

  • Drug, HuCNS-SC cells

Contact

  • Allison Intondi, PhD            510-456-4172 allison.intondi@stemcellsinc.com
  • Sarah Thayer, BS                510-456-4124 sarah.thayer@stemcellsinc.com

 

Sponsor: Neuralstem Inc.

For all information, including complete inclusion and exclusion criteria, as well as location of this trial, please follow link below.
https://www.clinicaltrials.gov/ct2/show/NCT01772810

Condition

  • Neurologic level of injury within cord segments T2-T12
  • SCI injury classified as AIS-A complete
  • At least 1 year but no more than 2 years from time of injury at the time of surgery
  • 18 Years to 65 Years

Intervention

  • Device, Human spinal cord stem cells.

Contact

  • Amber Faulise, B.S.           858-657-5175      rfaulise@ucsd.edu

 

Sponsor: InVivo Therapeutics

For all information, including complete inclusion and exclusion criteria, as well as location of this trial, please follow link below.
https://www.clinicaltrials.gov/ct2/show/study/NCT02138110

Condition

  • T3-T12/L1
  • AIS A traumatic spinal cord injury
  • SCI occurring within past 21 days
  • Aged 18 – 65 years

Intervention

  • Device: PLGA Poly-L-Lysine Scaffold

Contact

  • Kristin Neff            617-863-5581      kneff@invivotherapeutics.com

 

Sponsor: AOSpine North America Research Network

For all information, including complete inclusion and exclusion criteria, as well as location of this trial, please follow link below.
https://www.clinicaltrials.gov/ct2/show/study/NCT01597518

Condition

  • Level of Injury between C4-C8
  • SCI Impairment Scale Grade “A,” “B” or “C”
  • Able to receive the Investigational Drug within 12 hours of injury
  • Age between 18 and 75 years

Intervention

  • Drug: Riluzole
  • Drug: Placebo

Contact

  • Please follow link above to locate contact information by location study

 

Sponsor: Ekso Bionics Holdings, Inc

For all information, including complete inclusion and exclusion criteria, as well as location of this trial, please follow link below.
https://www.clinicaltrials.gov/ct2/show/NCT01701388

Condition

  • SCI between C7-S1
  • 18-65 years of age
  • Able to physically fit into the exoskeletal device.
  • Able to tolerate upright standing for a minimum of 30 minutes

Intervention

Device: Ekso exoskeleton

Contact

  • Arun Jayaraman, PhD        312-238-6875     ajayaraman@ric.org
  • Lori McGee Koch, BS         312-238-2091      lmcgee@ric.org

 

Sponsor: ReWalk Robotics Ltd

For all information, including complete inclusion and exclusion criteria, as well as location of this trial, please follow link below.
https://www.clinicaltrials.gov/ct2/show/NCT02104622

Condition

  • SCI level C6-8, T1-T12; L1-L5 incomplete or complete
  • 12 Years to 85 Years
  • Able to physically fit into the exoskeleton device
  • Able to tolerate upright standing for a minimum of 30 minutes;

Intervention

Device: ReWalk Rehabilitation 2.0

Contact

  • Kate Scanlan, DPT              312-238-1355      kscanlan@ricres.org
  • Lori McGee-Koch, BS         312-238-2091      lmkoch@ricres.org